Add like
Add dislike
Add to saved papers

Structure-dependent degradation of nitroimidazoles by cobalt-manganese layered double hydroxide catalyzed peroxymonosulfate process.

Chemosphere 2021 March
The increasing concentration of nitroimidazoles antibiotics (NIs) in the water environment has great threat to human and ecosystem security. Herein, the degradation rates of four NIs were found to vary with their molecular structures using Co3 Mn-layered double hydroxide (LDH) catalyzed peroxymonosulfate oxidation process. Specifically, the degradation efficiency of secnidazole (SNZ) was determined to be the highest with a reaction rate of 0.24 min-1 , which was 3.6, 2.3 and 1.8 times to that of menidazole (MZ), metronidazole (MTZ) and ornidazole (ONZ), respectively. During the reaction, 8.3% of Co2+ and 8.4% of Mn3+ transformed to Co3+ and Mn4+ after reaction, respectively. The conversion of bimetallic valence in Co3 Mn-LDH donated electrons (e- ) for PMS activation, resulting in the production of 1 O2 , OH, SO4 - and O2 - . Density functional theory (DFT) calculation showed that the presence of electron-donating groups (-CH3 and -OH) and the absence of electron-withdrawing atom (Cl) leaded to the richest active sites in the molecular structure of SNZ, which thus contributed to the highest degradation efficiency of SNZ. By deducing the structure-dependent degradation pathways of four NIs, the carbon chain of SNZ was found to be more easily attacked to form MTZ and MZ because of its unique active sites, resulting in the faster degradation rate of SNZ than MTZ and MZ. This study may provide a valuable insight into the effects of molecular structures on the degradation rates and transformation pathways of NIs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app